BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24453273)

  • 21. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
    Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis of xerostomia in patients with nasopharyngeal carcinoma after radiation therapy].
    Liu XK; Zeng ZY; Hong MH; Zhang AL; Cui NJ; Chen FJ
    Ai Zheng; 2004 May; 23(5):593-6. PubMed ID: 15142462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
    Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes.
    Alsbeih G; Al-Harbi N; Al-Hadyan K; El-Sebaie M; Al-Rajhi N
    Radiat Res; 2010 Apr; 173(4):505-11. PubMed ID: 20334523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma.
    Lastrucci L; Bertocci S; Bini V; Borghesi S; De Majo R; Rampini A; Pernici P; Gennari PG
    Radiol Med; 2017 Apr; 122(4):303-308. PubMed ID: 28070838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance sialography for investigating major salivary gland duct system after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
    Ou D; Zhang Y; He X; Gu Y; Hu C; Ying H; Zhu G; Wu Y; Mao J; Yue L; Shen X
    Int J Clin Oncol; 2013 Oct; 18(5):801-7. PubMed ID: 22892798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 gene.
    De Langhe S; De Ruyck K; Ost P; Fonteyne V; Werbrouck J; De Meerleer G; De Neve W; Thierens H
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):393-9. PubMed ID: 22658438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
    Pratesi N; Mangoni M; Mancini I; Paiar F; Simi L; Livi L; Cassani S; Buglione M; Grisanti S; Almici C; Polli C; Saieva C; Magrini SM; Biti G; Pazzagli M; Orlando C
    Radiother Oncol; 2011 Jun; 99(3):356-61. PubMed ID: 21704413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
    Bian X; Song T; Wu S
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.
    Werbrouck J; De Ruyck K; Duprez F; Veldeman L; Claes K; Van Eijkeren M; Boterberg T; Willems P; Vral A; De Neve W; Thierens H
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1187-95. PubMed ID: 19251090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
    Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Pan XB; Liu Y; Huang ST; Chen KH; Jiang YM; Zhu XD
    Medicine (Baltimore); 2019 Sep; 98(36):e17030. PubMed ID: 31490391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dynamic observation on the short-term change of xerostomia after intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma].
    Li Y; Zhao C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 50(1):33-7. PubMed ID: 25764925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma.
    Chan JW; Parvathaneni U; Yom SS
    Future Oncol; 2017 Feb; 13(5):425-431. PubMed ID: 27875901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.
    Kam MK; Leung SF; Zee B; Chau RM; Suen JJ; Mo F; Lai M; Ho R; Cheung KY; Yu BK; Chiu SK; Choi PH; Teo PM; Kwan WH; Chan AT
    J Clin Oncol; 2007 Nov; 25(31):4873-9. PubMed ID: 17971582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-treatment late complications of nasopharyngeal carcinoma.
    Lee CC; Ho CY
    Eur Arch Otorhinolaryngol; 2012 Nov; 269(11):2401-9. PubMed ID: 22249834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
    Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
    Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of reduced-volume, intensity-modulated radiation therapy on disease control in nasopharyngeal carcinoma.
    Lin YW; Chen CC; Lin LC; Lee SP
    PLoS One; 2015; 10(4):e0125283. PubMed ID: 25919285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiation Therapy.
    Lu S; Wei J; Sun F; Xiao W; Cai R; Zhen Z; Zhu J; Wang J; Huang J; Lu L; Sun X; Gao Y
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):45-51. PubMed ID: 30244159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.